The contributions of fasting and postprandial blood glucose increments to oxidative stress and inflammation in dyslipidemic type 2 diabetic patients with stable ischemic heart disease

International Journal of Cardiology

Volumn 227, Issue , 2017, Pages 611-616

  Djindjic, Boris ^a,b   Kostic, Tomislav ^b   Radovanovic, Zoran ^b   Djindjic, Natasa ^a   Lazovic, Marko ^b   Zivic, Misko ^a   Perisic, Zoran ^b   Krstic, Nebojsa ^b  

^a UNIVERSITY OF NI   (Serbia)

^b Clinical Center Ni   (Serbia)

Author keywords

Adhesive molecules; Diabetes mellitus; Fasting hyperglycemia; Inflammation; Ischemic heart disease; Oxidative stress; Postprandial hyperglycemia

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARBONYL DERIVATIVE; FIBRINOGEN; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; METFORMIN; PLASMA PROTEIN; SULFONYLUREA; VASCULAR CELL ADHESION MOLECULE 1; AUTACOID;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CASE CONTROL STUDY; CELL ADHESION; CONTROLLED STUDY; CORRELATION COEFFICIENT; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; SYSTOLIC BLOOD PRESSURE; BLOOD; DYSLIPIDEMIA; HEART MUSCLE ISCHEMIA; METABOLISM; PHYSIOLOGY;

BLOOD GLUCOSE; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FASTING; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OXIDATIVE STRESS; POSTPRANDIAL PERIOD;

EID: 85006056305     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.10.089     Document Type: Article

References (37)

1. [1] Garber, A.J., Postprandial dysmetabolism and the heart. Heart Fail. Clin. 8:4 (2012), 563–573.
2. [2] Mangge, H., Almer, G., Truschnig-Wilders, M., et al. Inflammation, adiponectin, obesity and cardiovascular risk. Curr. Med. Chem. 17:36 (2010), 4511–4520.
3. [3] Tuttolomondo, A., Di Raimondo, D., Pecoraro, R., et al. Atherosclerosis as an inflammatory disease. Curr. Pharm. Des. 18:28 (2012), 4266–4288.
4. [4] Ley, K., Miller, Y.I., Hedrick, C.C., Monocyte and macrophage dynamics during atherogenesis. Arterioscler. Thromb. Vasc. Biol. 31:7 (2011), 1506–1516.
5. [5] Liu, T.S., Pei, Y.H., Peng, Y.P., et al. Oscillating high glucose enhances oxidative stress and apoptosis in human coronary artery endothelial cells. J. Endocrinol. Investig. 37:7 (2014), 645–651.
6. [6] Singh, N., Singh, N., Kumar Singh, S., et al. Reduced antioxidant potential of LDL is associated with increased susceptibility to LDL peroxidation in type II diabetic patients. Int. J. Endocrinol. Metab. 10:4 (2012), 582–586.
7. [7] Ceriello, A., Oxidative stress and diabetes-associated complications. Endocr. Pract. 12:Suppl. 1 (2006), 60–62.
8. [8] Standl, E., Schnell, O., Ceriello, A., Postprandial hyperglycemia and glycemic variability: should we care?. Diabetes Care 34:Suppl. 2 (2011), S120–S127.
9. [9] Bosi, E., Scavini, M., Ceriello, A., et al. PRISMA study group. Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated type 2 diabetes: the PRISMA randomized trial. Diabetes Care 36:10 (2013), 2887–2894.
10. [10] Macisaac, R.J., Jerums, G., Intensive glucose control and cardiovascular outcomes in type 2 diabetes. Heart Lung Circ. 20:10 (2011), 647–654.
11. [11] Fox, K., Garcia, M.A., Ardissino, D., et al. Task force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: the task force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur. Heart J. 27:11 (2006), 1341–1381.
12. [12] American Diabetes Association, Standards of medical care in diabetes–2009. Diabetes Care 32:Suppl. 1 (2009), S13–S61.
13. [13] Pickering, T.G., Hall, J.E., Appel, L.J., et al. Subcommittee of professional and public education of the American Heart Association Council on high blood pressure research. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on high blood pressure research. Hypertension 45:1 (Jan 2005), 142–161.
14. [14] ESH/ESC Task Force for the Management of Arterial Hypertension, 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC task force for the management of arterial hypertension. J. Hypertens. 31:10 (2013), 1925–1938.
15. [15] American Diabetes Association, Classification and diagnosis of diabetes. Diabetes Care 39:Suppl. 1 (2016), S13–S22.
16. [16] Andreeva, J.L., Kozjemakin, A.L., Kiskun, A.A., Modifikacija metoda opredelnija perekisej lipidov testes tiobarbiturovoj kisloti. Lab. Delo 11 (1988), 41–43 (Russian).
17. [17] Levine, R.L., Williams, J.A., Stadtman, E.R., Shacter, E., Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 233 (1994), 346–357.
18. [18] Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1 (1951), 265–275.
19. [19] Wadley, A.J., Veldhuijzen van Zanten, J.J., Aldred, S., The interactions of oxidative stress and inflammation with vascular dysfunction in ageing: the vascular health triad. Age (Dordr.) 35:3 (2013), 705–718.
20. [20] Aryangat, A.V., Gerich, J.E., Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk. Vasc. Health Risk Manag. 6 (2010), 145–155.
21. [21] Cavalot, F., Petrelli, A., Traversa, M., et al. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga diabetes study. J. Clin. Endocrinol. Metab. 91:3 (2006), 813–819.
22. [22] Kikuchi, K., Nezu, U., Shirakawa, J., et al. Correlations of fasting and postprandial blood glucose increments to the overall diurnal hyperglycemic status in type 2 diabetic patients: variations with levels of HbA1c. Endocr. J. 57:3 (2010), 259–266.
23. [23] Taqueti, V.R., Di Carli, M.F., Jerosch-Herold, M., et al. Increased microvascularization and vessel permeability associate with active inflammation in human atheromata. Circ. Cardiovasc. Imaging 7:6 (2014), 920–929.
24. [24] Wannamethee, S.G., Lowe, G.D., Shaper, A.G., et al. The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men. Atherosclerosis 181:1 (2005), 101–108.
25. [25] Postadzhiyan, A.S., Tzontcheva, A.V., Kehayov, I., Finkov, B., Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes. Clin. Biochem. 41:3 (2008), 126–133.
26. [26] Jin, C., Lu, L., Zhang, R.Y., et al. Association of serum glycated albumin, C-reactive protein and ICAM-1 levels with diffuse coronary artery disease in patients with type 2 diabetes mellitus. Clin. Chim. Acta 408:1–2 (2009), 45–49.
27. [27] Gustavsson, C.G., Agardh, C.D., Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range. Eur. Heart J. 25:23 (2004), 2120–2124.
28. [28] Kaptoge, S., Di Angelantonio, E., Lowe, G., et al. Emerging risk factors collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375:9709 (2010), 132–140.
29. [29] Walter, M.F., Jacob, R.F., Jeffers, B., et al. PREVENT study. Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: a longitudinal analysis of the PREVENT study. J. Am. Coll. Cardiol. 44:10 (2004), 1996–2002.
30. [30] Zheng, F., Lu, W., Jia, C., et al. Relationships between glucose excursion and the activation of oxidative stress in patients with newly diagnosed type 2 diabetes or impaired glucose regulation. Endocrine 37:1 (2010), 201–208.
31. [31] Yubero-Serrano, E.M., Delgado-Lista, J., Alcala-Diaz, J.F., et al. A dysregulation of glucose metabolism control is associated with carotid atherosclerosis in patients with coronary heart disease (CORDIOPREV-DIAB study). Atherosclerosis, 2016.
32. [32] Piga, R., Naito, Y., Kokura, S., et al. Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells. Atherosclerosis 193:2 (2007), 328–334.
33. [33] Dalle-Donne, I., Giustarini, D., Colombo, R., et al. Protein carbonylation in human diseases. Trends Mol. Med. 9:4 (2003), 169–176.
34. [34] Saha, A., Adak, S., Chowdhury, S., Bhattacharyya, M., Enhanced oxygen releasing capacity and oxidative stress in diabetes mellitus and diabetes mellitus-associated cardiovascular disease: a comparative study. Clin. Chim. Acta 361:1–2 (2005), 141–149.
35. [35] Neelofar, K., Arif, Z., Alam, K., Ahmad, J., Hyperglycemia induced structural and functional changes in human serum albumin of diabetic patients: a physico-chemical study. Mol. BioSyst. 12:8 (2016), 2481–2489.
36. [36] Pasterk, L., Lemesch, S., Leber, B., et al. Oxidized plasma albumin promotes platelet-endothelial crosstalk and endothelial tissue factor expression. Sci. Rep., 6, 2016, 22104.
37. [37] Frohnert, B.I., Sinaiko, A.R., Serrot, F.J., et al. Increased adipose protein carbonylation in human obesity. Obesity (Silver Spring) 19:9 (2011), 1735–1741.